미국의 의료용 전기 및 전기 치료 기구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends:

The U.S. electro-medical and electrotherapeutic apparatus market size is anticipated to reach USD 37.91 billion by 2030, and is expected to expand at a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Key factors driving market growth include the increasing prevalence of chronic disorders, advancements in technology, the growing preference for minimally invasive treatment options among patients and, the rising geriatric population. For instance, according to data from the Population Reference Bureau, the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. By 2050, this age group is expected to account for 23% of the total U.S. population, up from 17% in 2022.

The growing prevalence of chronic disorders is a major concern in the U.S., with diseases such as diabetes, cardiovascular conditions, respiratory disorders, and neurological diseases such as Alzheimer's and Parkinson's becoming increasingly common. For instance, according to the American Diabetes Association, in 2021, 38.4 million Americans, or 11.6% of the population, were living with diabetes. Among them, 2 million individuals have type 1 diabetes, including approximately 304,000 children and adolescents. These conditions place a significant strain on healthcare systems and demand advanced diagnostic, therapeutic, and monitoring solutions. As the population ages and lifestyle factors contribute to the rise of these chronic illnesses, the need for effective management and treatment options continues to grow, driving the demand for electro-medical and electrotherapeutic devices.

Technological advancements are expected to significantly boost the growth of the U.S. electro-medical and electrotherapeutic apparatus market as companies continue to innovate and introduce new, advanced products. Market players are increasingly focused on developing advanced devices that address the evolving healthcare needs of patients and healthcare providers. A key aspect of this innovation is the integration of advanced technologies such as artificial intelligence, wearable devices, and continuous monitoring systems into medical equipment. As a result, companies are seeking regulatory approvals from government bodies, such as the U.S. Food and Drug Administration (FDA), to bring these new technologies to market. In June 2024, Abbott announced that the FDA had cleared two new over-the-counter continuous glucose monitoring (CGM) systems - Lingo and Libre Rio. Both products are built on Abbott's well-established FreeStyle Libre CGM technology, which is already used by around 6 million people globally. These innovations reflect the ongoing efforts of companies to enhance healthcare solutions and meet the growing demand for advanced, accessible diagnostic tools.

U.S. Electro-medical And Electrotherapeutic Apparatus Market Highlights

• Diagnostic equipment segment dominated the product segment by capturing a share of 38.2% in 2024.
• The therapeutic equipment segment is anticipated to grow at the fastest CAGR during the forecast period.
• On the basis of application cardiology segment held the largest market share by capturing a share of 28.3% in 2024.
• Neurology segment is expected to grow at a fastest rate during the forecast period.
• Among end use, hospitals held a majority share of the market of 45.8% in 2024.
• Diagnostic centers segment is expected to grow at a fastest rate over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End use
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Rising prevalence of chronic disorders
    • 3.4.1.2. Rising geriatric population
    • 3.4.1.3. Growing focus on non-invasive and minimally invasive treatments
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High cost of advanced devices
    • 3.4.2.2. Lack of skilled healthcare professionals
• 3.5. U.S. Electro-medical and Electrotherapeutic Apparatus Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape

Chapter 4. U.S. Electro-medical and Electrotherapeutic Apparatus Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Electro-medical and Electrotherapeutic Apparatus Product Market Movement Analysis
• 4.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Diagnostic Equipment
  • 4.4.1. Diagnostic equipment market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Therapeutic Equipment
  • 4.5.1. Therapeutic equipment market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Surgical Devices
  • 4.6.1. Surgical devices market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Patient Assistive Devices
  • 4.7.1. Patient assistive devices market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. Electro-medical and Electrotherapeutic Apparatus Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Electro-medical and Electrotherapeutic Apparatus Application Market Movement Analysis
• 5.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Cardiology
  • 5.4.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Neurology
  • 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Orthopedics
  • 5.7.1. Orthopedics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Gynecology
  • 5.8.1. Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Urology
  • 5.9.1. Urology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Electro-medical and Electrotherapeutic Apparatus Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Electro-medical and Electrotherapeutic Apparatus End Use Market Movement Analysis
• 6.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Diagnostic Centers
  • 6.6.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2024
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators and Leaders
• 7.6. Company Profiles
  • 7.6.1. GE HealthCare
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Koninklijke Philips N.V.
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. Siemens Healthineers AG
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Medtronic
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Abbott
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. Boston Scientific Corporation
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. Fujifilm Holdings Corporation
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. Zimmer Biomet
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Nihon Kohden Corporation
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. OMRON Healthcare, Inc.
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives
  • 7.6.11. Invacare Corporation
    • 7.6.11.1. Company overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Product benchmarking
    • 7.6.11.4. Strategic initiatives